ABSTRACT

Discontinuation of in-Home Isolation for Immunocompromised Persons with COVID-19 (Interim Guidance)   [open pdf - 109KB]

From the Document: "Limited information is available to characterize the spectrum of clinical illness, transmission efficiency, and the duration of viral shedding for immunocompromised persons with novel coronavirus disease (COVID-19). Experience from other respiratory viral infections, in particular influenza, suggests that persons with COVID-19 may shed detectable viral material and potentially infectious virus for an extended period of time after recovery. Where there is concern that immunocompromised persons (e.g., medical treatment with immunosuppressive drugs, bone marrow or solid organ transplant recipients, inherited immunodeficiency, poorly controlled HIV) may continue to shed virus after recovery, jurisdictions may wish to consider the utility of a test-based strategy. However, a test-based strategy is contingent on the availability of ample testing supplies and laboratory capacity as well as convenient access to testing and in the absence of these conditions may not be feasible."

Publisher:
Date:
2020-03-16
Series:
Copyright:
Public Domain
Retrieved From:
Centers for Disease Control and Prevention: https://www.cdc.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations